Quality of physician communication about human papillomavirus vaccine: findings from a national survey
- PMID: 26494764
- PMCID: PMC4633386
- DOI: 10.1158/1055-9965.EPI-15-0326
Quality of physician communication about human papillomavirus vaccine: findings from a national survey
Abstract
Background: Improving the quality of physicians' recommendations for human papillomavirus (HPV) vaccination is critical to addressing low coverage. Thus, we sought to describe HPV vaccine communication practices among primary care physicians.
Methods: Pediatricians and family physicians (n = 776) completed our national online survey in 2014. We assessed the quality of their HPV vaccine recommendations on strength of endorsement (i.e., saying the vaccine is important), timeliness (recommending it by ages 11-12), consistency (recommending it routinely vs. using a risk-based approach), and urgency (recommending same-day vaccination).
Results: A sizeable minority of physicians reported that they do not strongly endorse HPV vaccine (27%) or deliver timely recommendations for girls (26%) or boys (39%). Many physicians (59%) used a risk-based approach to recommending HPV vaccine, and only half (51%) usually recommended same-day vaccination. Overall recommendation quality was lower among physicians who were uncomfortable talking about HPV vaccine or who believed parents did not value it. Quality was higher among physicians who began discussions by saying the child was due for HPV vaccine versus giving information or eliciting questions.
Conclusion: Many physicians in our national sample reported recommending HPV vaccine inconsistently, behind schedule, or without urgency. These practices likely contribute to under-immunization among adolescents, and may convey ambivalence to parents.
Impact: As one of the first studies to assess multiple aspects of recommendation quality, these findings can inform the many state and national initiatives that aim to improve communication about HPV vaccine so as to address the persistent underuse of a powerful tool for cancer prevention.
©2015 American Association for Cancer Research.
Conflict of interest statement
Figures
Comment in
-
"A day late and a dollar short": physicians and HPV vaccination.Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1643-4. doi: 10.1158/1055-9965.EPI-15-0879. Epub 2015 Oct 22. Cancer Epidemiol Biomarkers Prev. 2015. PMID: 26494765 No abstract available.
-
Quality of Physician Communication about HPV Vaccine-Letter.Cancer Epidemiol Biomarkers Prev. 2016 May;25(5):865. doi: 10.1158/1055-9965.EPI-15-1303. Epub 2016 Feb 10. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 26908431 No abstract available.
-
Quality of Physician Communication about HPV Vaccine-Letter.Cancer Epidemiol Biomarkers Prev. 2016 May;25(5):867. doi: 10.1158/1055-9965.EPI-16-0049. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 27197143 No abstract available.
Similar articles
-
Improving Physician Recommendations for Human Papillomavirus Vaccination: The Role of Professional Organizations.Sex Transm Dis. 2017 Jan;44(1):42-47. doi: 10.1097/OLQ.0000000000000543. Sex Transm Dis. 2017. PMID: 27898573 Free PMC article.
-
Physician communication about adolescent vaccination: How is human papillomavirus vaccine different?Prev Med. 2015 Aug;77:181-5. doi: 10.1016/j.ypmed.2015.05.024. Epub 2015 Jun 4. Prev Med. 2015. PMID: 26051197 Free PMC article.
-
The content and context of physicians' communication with males about human papillomavirus vaccination.Hum Vaccin Immunother. 2016 Jun 2;12(6):1511-8. doi: 10.1080/21645515.2015.1132963. Epub 2016 Feb 2. Hum Vaccin Immunother. 2016. PMID: 26835599 Free PMC article.
-
Human papillomavirus vaccine in adolescent women: a 2012 update.Curr Opin Obstet Gynecol. 2012 Oct;24(5):305-10. doi: 10.1097/GCO.0b013e3283567005. Curr Opin Obstet Gynecol. 2012. PMID: 22781077 Review.
-
Improving adolescent health: focus on HPV vaccine acceptance.J Adolesc Health. 2005 Dec;37(6 Suppl):S17-23. doi: 10.1016/j.jadohealth.2005.09.010. J Adolesc Health. 2005. PMID: 16310137 Review.
Cited by
-
Variation in Human Papillomavirus Vaccine Uptake and Acceptability Between Female and Male Adolescents and Their Caregivers.J Community Health. 2017 Jun;42(3):522-532. doi: 10.1007/s10900-016-0284-5. J Community Health. 2017. PMID: 27778139 Free PMC article.
-
Missing the Target for Routine Human Papillomavirus Vaccination: Consistent and Strong Physician Recommendations Are Lacking for 11- to 12-Year-Old Males.Cancer Epidemiol Biomarkers Prev. 2016 Oct;25(10):1435-1446. doi: 10.1158/1055-9965.EPI-15-1294. Epub 2016 Aug 2. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 27486020 Free PMC article.
-
Messages to Motivate Human Papillomavirus Vaccination: National Studies of Parents and Physicians.Cancer Epidemiol Biomarkers Prev. 2016 Oct;25(10):1383-1391. doi: 10.1158/1055-9965.EPI-16-0224. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 27694109 Free PMC article.
-
Effect of a School-Based Educational Intervention About the Human Papillomavirus Vaccine on Psychosocial Outcomes Among Adolescents: Analysis of Secondary Outcomes of a Cluster Randomized Trial.JAMA Netw Open. 2021 Nov 1;4(11):e2129057. doi: 10.1001/jamanetworkopen.2021.29057. JAMA Netw Open. 2021. PMID: 34726749 Free PMC article. Clinical Trial.
-
Prioritizing and implementing HPV vaccination quality improvement programs in healthcare systems: the perspective of quality improvement leaders.Hum Vaccin Immunother. 2021 Oct 3;17(10):3577-3586. doi: 10.1080/21645515.2021.1913965. Epub 2021 Jun 21. Hum Vaccin Immunother. 2021. PMID: 34152924 Free PMC article.
References
-
- President’s Cancer Panel Annual Report. Accelerating HPV vaccine uptake: urgency for action to prevent cancer. A report to the President of the United States from the President’s Cancer Panel. Bethesda, MD: National Cancer Institute; 2014.
-
- Crowe E, Pandeya N, Brotherton JM, Dobson AJ, Kisely S, Lambert SB, et al. Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia. BMJ. 2014;348:g1458. - PMC - PubMed
-
- Ali H, Donovan B, Wand H, Read TR, Regan DG, Grulich AE, et al. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ. 2013;346:f2032. - PubMed
-
- Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep. 2014;63:1–30. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials